Nursing

•Download as PPT, PDF•

0 likes•212 views

chivandt

Health & Medicine Career

Job Description ,[object Object],[object Object],[object Object]

Working Condition ,[object Object],[object Object],[object Object]

References ,[object Object],[object Object]

What's hot

RESUME

Marly Jiby RN-Resume

COVER LETTER 090116

ROSY CV

ULA MARIE WONG - CV

JANETTE EDWARDS_Resume_Sales

Jan Edwards

Portfolio Connie Barrow Example

Constance Barrow

Sobia Qadeer Resume updated

CV PCES

Massage Therapy

Alicia profile

RESUME.KR

Hamza_Saleem_CV

Hamza Mohammed Saleem

DR WARIS

Md Waris Heyat Gayawi

shumaila cv

Dr-Dina Said CV

C.v

Ryan Garding Resume

PERCEPTIONS OF PROFESSIONAL IDENTITY

Gylo Hercelinskyj

What's hot (20)

RESUME

Marly Jiby RN-Resume

COVER LETTER 090116

ROSY CV

ULA MARIE WONG - CV

JANETTE EDWARDS_Resume_Sales

Portfolio Connie Barrow Example

Sobia Qadeer Resume updated

CV PCES

Massage Therapy

Alicia profile

RESUME.KR

Hamza_Saleem_CV

DR WARIS

shumaila cv

Dr-Dina Said CV

C.v

Ryan Garding Resume

PERCEPTIONS OF PROFESSIONAL IDENTITY

Viewers also liked

Lead generation and Incubation

Zoologist

Georges buffon

Ciberassetjament

Dr. wilfred gordon bigelow

chivandt

Cardiac surgeon

chivandt

Fibrocell Power Point

Fibrocell Science Inc.

Diversifying Your Practice for Financial Gain and Survival

esaribalbs

Iris e emilly 5º ano b

Priscila Furtado

Research geneticist

chivandt

Nature conservation officer

chivandt

Iris e emilly 5º ano b

Priscila Furtado

Paleontologist

chivandt

Sidney altman

chivandt

Don’t Bite the Hand!

Tania Huycke-Phillips

Don’t Bite Me!

Tania Huycke-Phillips

Internet safety power_point

Amit Pal Singh

Viewers also liked (17)

Lead generation and Incubation

Zoologist

Georges buffon

Ciberassetjament

Dr. wilfred gordon bigelow

Cardiac surgeon

Fibrocell Power Point

Diversifying Your Practice for Financial Gain and Survival

Iris e emilly 5º ano b

Research geneticist

Nature conservation officer

Iris e emilly 5º ano b

Paleontologist

Sidney altman

Don’t Bite the Hand!

Don’t Bite Me!

Internet safety power_point

Recently uploaded

RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0). CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.

Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...

Oleg Kshivets

1130525--家醫計畫2.0糖尿病照護研討會-社團法人高雄市醫師公會.pdf

Ks doctor

Book Trailer: PGMEE in a Nutshell (CEE MD/MS PG Entrance Examination)

Dr. Aryan (Anish Dhakal)

How to Give Better Lectures: Some Tips for Doctors

LanceCatedral

Impact of cancers therapies on the loss in cardiac function, myocardial fffic...

Catherine Liao

### Understanding Wealth: A Comprehensive Guide Wealth is a multifaceted concept that extends beyond mere financial assets. It encompasses a range of elements including money, investments, property, and other valuable resources. However, true wealth also includes non-material aspects such as health, relationships, and personal fulfillment. This guide delves into the various dimensions of wealth, exploring how it can be created, sustained, and enjoyed. #### Defining Wealth Traditionally, wealth is defined as the abundance of valuable resources or material possessions. It includes financial assets like cash, savings, stocks, bonds, and real estate. However, a broader understanding of wealth considers factors such as personal well-being, emotional health, social connections, and intellectual growth. This holistic view recognizes that true wealth is not solely about accumulating money but also about enhancing one's quality of life. #### The Importance of Financial Wealth Financial wealth remains a critical component of overall wealth. It provides security, freedom, and the ability to pursue opportunities. Key elements of financial wealth include: 1. **Savings**: Money set aside for future use. It is crucial for emergencies, large purchases, and financial goals. 2. **Investments**: Assets purchased with the expectation that they will generate income or appreciate over time. Common investments include stocks, bonds, mutual funds, real estate, and businesses. 3. **Income**: Regular earnings from work, investments, or other sources. Consistent income is essential for maintaining and growing wealth. 4. **Debt Management**: Effectively managing debt ensures that it does not erode financial wealth. This includes paying off high-interest debt and using credit wisely. #### Creating Wealth Creating wealth involves generating and accumulating financial and non-financial resources. The process can be broken down into several key strategies: 1. Education and Skill Development: Investing in education and skills enhances earning potential. Higher education, professional certifications, and continuous learning can lead to better job opportunities and higher salaries. 2. Entrepreneurship: Starting and running a successful business can be a significant source of wealth. Entrepreneurship requires innovation, risk-taking, and effective management. 3. Investing: Making smart investments is essential for wealth creation. This involves understanding different types of investments, assessing risks, and making informed decisions. Diversifying investments can reduce risk and increase potential returns. 4. Saving and Budgeting: Effective saving and budgeting help accumulate wealth over time. Setting financial goals, creating a budget, and sticking to it are foundational steps in wealth creation. 5. Real Estate: Investing in property can provide rental income and capital appreciation. Real estate is a tangible asset that can hedge against inflation

Mastering Wealth: A Path to Financial Freedom

FatimaMary4

ANATOMY OF THE LOWER URINARY TRACT AND MALE [Autosaved] [Autosaved].pptx

Bright Chipili

5cl adbb 5cladba cheap and fine Telegram: +85297504341

Sherrylee83

i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource. This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and Associate Division Director for Ambulatory Operations The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma. STATEMENT OF NEED Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL. Target Audience Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL). Learning Objectives 1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL 2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults 3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection

New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...

i3 Health

June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels: - ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING - WOMEN’S HEALTH: FERTILITY PRESERVATION - WHAT’S NEW IN THE TREATMENT OF INFECTIOUS, ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES? - ARTIFICIAL INTELLIGENCE AND ETHICS - GENE THERAPY - BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE - ETHICAL CHALLENGES IN LIFE SCIENCES - Prix Galien International Awards Ceremony

Prix Galien International 2024 Forum Program

Levi Shapiro

Couples presenting to the infertility clinic- Do they really have infertility...

Sujoy Dasgupta

DECIPHERING COMMON ECG FINDINGS IN ED.pptx

drwaque

Presentació "Advancing Emergency Medicine Education through Virtual Reality"

Badalona Serveis Assistencials

The hemodynamic and autonomic determinants of elevated blood pressure in obes...

Catherine Liao

TEST BANK For Williams' Essentials of Nutrition and Diet Therapy, 13th Editio...

kevinkariuki227

Thoracotomy is the surgical procedure with an incision made to access the pleural space and the contents of the thoracic cavity. Given the structures to be accessed with in the cavity, different incisions have been established to easy the procedure and these incisions qualify the types of thoracotomies to be studied hereunder. PRE OP OPTIMIZATION FOR SPECIFIC FACTORS The outcome of surgical procedures is not measured only by clinical end points but also shorter stays and lower costs. Patients’ discharge is delayed commonly due to inadequate pain relief, infection, arrhythmias, prolonged air leak and debility. Many complications that occur from thoracic operations can be anticipated. An aggressive preoperative work up mitigates morbidity and shortens convalescence. APPROACH CONSIDERATIONS There are about three principles that can guides the choice of the thoracotomy incision to be used I. Adequate exposure must be achieved. The choice of incision is aided by a thorough understanding of the surface anatomy and a comprehensive review of the radiographic images that are obtained preoperatively. II. Chest-wall function and appearance should be preserved to the extent possible. This principle include non-spreading video-assisted thoracoscopic surgery (VATS) procedures, muscle-sparing techniques, avoidance of excessive rib retraction, and rib preservation when possible. III. The third principle is that closure must be meticulous and appropriate. Strict layered closure is the rule for thoracic surgical incisions. Every effort should be made to approximate the individual divided chest-wall muscles in appropriate layers; otherwise, a significant delay in the recovery of range of motion (ROM) may result. Care must be taken to avoid over approximating the ribs and to prevent an override; this will help minimize postoperative pain. POST-OPERATIVE CARE AND MONITORING

THORACOTOMY . SURGICAL PERSPECTIVES VOL 1

DR SETH JOTHAM

Linearity concept of significance, standard deviation, chi square test, students T- test, ANOVA test , pharmaceutical science, statistical analysis, statistical methods, optimization technique, modern pharmaceutics, pharmaceutics, mpharm 1 unit i sem, 1 year m pharm, applications of chi square test, application of standard deviation , pharmacy, method to compare dissolution profile, statistical analysis of dissolution profile, important statical analysis, m. pharmacy, graphical representation of standard deviation, graph of chi square test, graph of T test , graph of ANOVA test ,formulation of t test, formulation of chi square test, formula of standard deviation.

linearity concept of significance, standard deviation, chi square test, stude...

KavyasriPuttamreddy

Relationship between vascular system disfunction, neurofluid flow and Alzheim...

Catherine Liao

CURRENT HEALTH PROBLEMS AND ITS SOLUTION BY AYURVEDA.pptx

Dr KHALID B.M

Antiplatelets in IHD, Dose Duration, DAPT vs SAPT

AkashGanganePatil1

Recently uploaded (20)

Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...

1130525--家醫計畫2.0糖尿病照護研討會-社團法人高雄市醫師公會.pdf

Book Trailer: PGMEE in a Nutshell (CEE MD/MS PG Entrance Examination)

How to Give Better Lectures: Some Tips for Doctors

Impact of cancers therapies on the loss in cardiac function, myocardial fffic...

Mastering Wealth: A Path to Financial Freedom

ANATOMY OF THE LOWER URINARY TRACT AND MALE [Autosaved] [Autosaved].pptx

5cl adbb 5cladba cheap and fine Telegram: +85297504341

New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...

Prix Galien International 2024 Forum Program

Couples presenting to the infertility clinic- Do they really have infertility...

DECIPHERING COMMON ECG FINDINGS IN ED.pptx

Presentació "Advancing Emergency Medicine Education through Virtual Reality"

The hemodynamic and autonomic determinants of elevated blood pressure in obes...

TEST BANK For Williams' Essentials of Nutrition and Diet Therapy, 13th Editio...

THORACOTOMY . SURGICAL PERSPECTIVES VOL 1

linearity concept of significance, standard deviation, chi square test, stude...

Relationship between vascular system disfunction, neurofluid flow and Alzheim...

CURRENT HEALTH PROBLEMS AND ITS SOLUTION BY AYURVEDA.pptx

Antiplatelets in IHD, Dose Duration, DAPT vs SAPT

Nursing

1. Nurse Practitioner By Chivand Thear Kass SBI3U0 Jan 25, 2012

Nursing

Recommended

Recommended

More Related Content

What's hot

What's hot (20)

Viewers also liked

Viewers also liked (17)

Recently uploaded

Recently uploaded (20)

Nursing